# FDA recall D-0181-2023

> **Glaxosmithkline Consumer Healthcare Holdings DBA Haleon** · Class I · drug recall initiated 2022-12-06.

## Product

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b)	200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940

## Reason for recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0181-2023
- **Recalling firm:** Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-06
- **Report date:** 2023-02-01
- **Termination date:** 2024-02-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Warren, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0181-2023

## Citation

> AI Analytics. FDA recall D-0181-2023. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-0181-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*